Novel compounds are disclosed which inhibit the activity of phospholipase enzymes in a mammal, particularly cytosolic phospholipase A
2
. Pharmaceutical compositions comprising such compounds and methods of treatment using such compositions are also disclosed.
本发明披露了一种新型化合物,可抑制哺乳动物中
磷脂酶酶活性,特别是细胞质
磷脂酶A2。本发明还披露了包括这些化合物的制药组合物和使用这些组合物的治疗方法。